Search research articles
Contact Us
Filters
Showing results (221-230 of 238) with videos related to
Page
of 24
Sort By:
The Lancet. Oncology
|
June 6, 2022
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
David J Pinato, Juan Aguilar-Company, Daniela Ferrante, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study
Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, et al.
Cancer Discovery
|
August 2, 2020
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
David J Pinato, Alberto Zambelli, Juan Aguilar-Company, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers
Margherita Rimini, Lorenzo Fornaro, Masafumi Ikeda, et al.
Journal of Hepatology
|
November 16, 2023
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
Ciro Celsa, Giuseppe Cabibbo, Claudia A M Fulgenzi, et al.
The Lancet. Oncology
|
March 10, 2023
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Alessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 2021
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
David J Pinato, Lorenza Scotti, Alessandra Gennari, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 18, 2025
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity
Alessio Cortellini, Edoardo Garbo, Giulia La Cava, et al.
Journal of the National Cancer Institute
|
April 13, 2022
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
Alessio Cortellini, Alessandra Gennari, Fanny Pommeret, et al.
JAMA Oncology
|
November 24, 2021
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry
, David J Pinato, Meera Patel, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 238) with videos related to
Sort By:
Page
of 24
The Lancet. Oncology
|
June 6, 2022
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
David J Pinato, Juan Aguilar-Company, Daniela Ferrante, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study
Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, et al.
Cancer Discovery
|
August 2, 2020
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
David J Pinato, Alberto Zambelli, Juan Aguilar-Company, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers
Margherita Rimini, Lorenzo Fornaro, Masafumi Ikeda, et al.
Journal of Hepatology
|
November 16, 2023
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
Ciro Celsa, Giuseppe Cabibbo, Claudia A M Fulgenzi, et al.
The Lancet. Oncology
|
March 10, 2023
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Alessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 2021
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
David J Pinato, Lorenza Scotti, Alessandra Gennari, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 18, 2025
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity
Alessio Cortellini, Edoardo Garbo, Giulia La Cava, et al.
Journal of the National Cancer Institute
|
April 13, 2022
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
Alessio Cortellini, Alessandra Gennari, Fanny Pommeret, et al.
JAMA Oncology
|
November 24, 2021
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry
, David J Pinato, Meera Patel, et al.
Page
of 24